Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IMUX
IMUX logo

IMUX Earnings

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Quarterly Results

IMUX logo
IMUX
FY2025Q3
2025-11-13
Revenue
$0
(est)
-
EPS
$0.18(est)
AI Prediction
-
Calendar ReportReport
IMUX logo
IMUX
2025-03-20
Revenue
$0
(est)
-
EPS
$0.24(est)
AI Prediction
-
IMUX logo
IMUX
FY2024Q2
2024-08-08 00:00:00
pre market
Pre-Market
Revenue
$0
(est)
-
EPS
-$0.21
-8.70%
AI Prediction
-
Calendar WebcastAttend Webcast

IMUX Earnings Forecast

Looking ahead, IMUX remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of undefined and an EPS of -0.11.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2026 have been unchanged by 0%, while EPS estimates have been unchanged by 0%. For the upcoming , revenue estimates have been adjusted revised upward by 82.33%. These revisions correlate with a 0% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in IMUX long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
1Y
3Y
5Y
Currency: USD
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0
Revenue Estimates for FY2026
No Change
down
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down
0.00%
In Past 3 Month
Stock Price
Go Up
up
+82.33%
In Past 3 Month

Earnings Forecast

Revenue
EPS
Currency:
No data

No data

Actual
Estimate
AI Analysis

Earnings Surprise Analysis

Revenue
EPS
1Y
3Y
AI Analysis
Earnings Reaction
The chart below shows how IMUX performed 10 days before and after its earnings report, based on data from the past quarters. Typically, IMUX sees a 52.5% change in stock price 10 days leading up to the earnings, and a -0.12% change 10 days following the report. On the earnings day itself, the stock moves by -0.7%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed 9.26% on the day following the earnings release and then changed by -0.08% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.

People Also Watch

Frequently Asked Questions

What were the key highlights of IMUX's latest earnings report for FY2025Q3?

IMUX reported its FY2025Q3 earnings on 2025-11-13, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.18 by 0%. The stock experienced a -3% price change on the earnings day and a 7.88% change over the next five days, reflecting market reactions to the results.

How did IMUX's stock price react after the FY2025Q3 earnings release?

Following IMUX's FY2025Q3 earnings announcement on 2025-11-13, the stock price moved by -3% on the day of the release. Over the subsequent five days, it saw a 7.88% change. Historically, IMUX's stock price tends to shift by an average of 52.5% in the 10 days leading up to earnings and -0.12% in the 10 days following, providing insight into potential market.

What are the revenue and EPS estimates for IMUX for ?

For , analysts estimate IMUX's annual revenue to reach undefined, while the EPS is projected at -0.11. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates revised upward by 82.33% over the past three months, indicating analyst expectation in the company's performance.

How does IMUX's stock price correlate with earnings forecast revisions?

The correlation between IMUX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved revised upward by 82.33%. This trend suggests that price dips could present buying opportunities for investors.

What should investors expect from IMUX's next earnings report?

Based on historical trends, IMUX's stock price typically moves by 52.5% in the 10 days before its earnings and -0.12% in the 10 days after. For the upcoming earnings, analysts expect an EPS of -0.11 and revenue of undefined.

What is the sentiment in Immunic, Inc. (IMUX) Q3 2024 Earnings Call Summary?

The earnings call summary indicates financial challenges with ongoing net losses and increased expenses, despite having cash to fund operations into Q3 2025. There are competitive and supply chain risks, and a lack of shareholder return plans. The Q&A reveals management's unclear responses and inability to provide guidance, raising uncertainty. While there is interest in partnerships, no specific details were provided. Overall, these factors suggest a negative sentiment, likely leading to a stock price decline in the range of -2% to -8% over the next two weeks.